Note: These positions have been filled for the 2014 - 2015 residency year.
Program Type: ASHP-Accredited PGY2 Oncology
ASHP Match Number: 537860
Purpose Statement: The purpose of the PGY2 Oncology Practice Residency is to provide concentrated training focused on the care of patients with cancer. Pharmacists completing this program will be highly-qualified independent practitioners able to provide and be responsible for drug therapy outcomes for individualized patients as an integral member of the multidisciplinary healthcare team. Graduates from this program can be expected to successfully sit for board certification (BCOP) when eligible, perform practice-related research, deliver effective training and education, and serve institutions as an authoritative resource on oncology pharmacotherapy issues as a pharmacy clinical specialist.
Program Overview: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is a National Cancer Institute (NCI)-designated Cancer Center and one of the 21 cancer centers within the National Comprehensive Cancer Network. Pharmaceutical care for the oncology patients in the Weinberg Building is provided through a pharmacy satellite located within the facility that operates 24 hours a day. Over the course of a year the resident will become comfortable recognizing and managing cancer- and treatment-related complications, such as pain, infection, alterations in fluids/electrolytes/nutrition, hematologic toxicities and gastrointestinal toxicities. Emphasis will be placed on gaining knowledge and skills to manage and provide recommendations for antineoplastics. Residents will also gain clinical research skills and be involved in different aspects of clinical trials. Upon completion of this residency training, the resident will have developed the clinical skills necessary to practice as an oncology clinical specialist.
- Management of a diverse group of solid and hematologic malignancies
- Familiarity with investigational cancer treatments as well as standard of care
- Multidisciplinary patient care rounds
- Patient and caregiver education
- Multidisciplinary conferences including: Oncology Grand Rounds, Oncology Journal Club, Oncology Pain Conference, and disease-specific case conferences
- Teaching opportunities within the cancer center as well as the University of Maryland School of Pharmacy
Rotations: Ten months are devoted to orientation and core experiences; two months are available for electives. Residents will also participate in a longitudinal Oncology Anticoagulation clinic.
- Medical Oncology
- Hematologic Malignancies (2 months)
- Bone Marrow Transplant
- Ambulatory Oncology (2 months)
- Pain and Palliative Care
- Pediatric Oncology
- Oncology Investigational Drug Service
- Oncology Practice Administration
- Immunocompromised Infectious Disease
- Gynecology Oncology
- Radiation Oncology
Application Information: All applications will be accepted through PHORCAS:
Program Director: Bradley Burton, PharmD, BCOP, CACP
Title: Clinical Specialist, Medical Oncology
Education: Doctor of Pharmacy, University of North Carolina at Chapel Hill
Training: Pharmacy Practice Residency - University of Maryland Pharmacy Residency and Fellowship Programs
Oncology Specialty Residency - University of Maryland Pharmacy Residency and Fellowship Programs
Dr. Burton is the clinical pharmacy specialist in medical oncology at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital. He is also the Director of the PGY-2 Oncology Residency Program at Johns Hopkins and serves as an Assistant Clinical Professor with the University of Maryland School of Pharmacy. Dr. Burton received his Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill, and completed his Pharmacy Practice and Oncology Specialty Residencies at the University of Maryland Medical Center through the University of Maryland Pharmacy Residency and Fellowship Programs. His practice interests include gastrointestinal malignancies, genitourinary malignancies, supportive care, and anticoagulation in patients with cancer.
Dr. Burton currently serves as the ASHP Hematology/Oncology Network Facilitator for the 2012-2014 cycle. In addition to this Dr. Burton is an active member, and past Networking and Education Committee Co-chair of the District of Columbia College of Clinical Pharmacy, and is also active in several institutional committees and task forces.
Contact InformationBradley Burton, PharmD, BCOP, CACP
Clinical Pharmacy Specialist, Medical Oncology
Program Director, PGY2 Oncology Residency
The Johns Hopkins Hospital
600 North Wolfe Street/Carnegie 180
Baltimore, MD 21287